Interpace Biosciences IDXG
OTC IDXG
$6.50 +1.10 (+20.37%)
At close: Oct 23, 2026 · 4:00 PM EDT

Interpace Biosciences (IDXG) Long-Term Deferred Tax (2025 - 2026)

Updated

Interpace Biosciences (IDXG) recorded Long-Term Deferred Tax of $20.92 million in Q2 2026, down 0.3% from the prior quarter.

Analysis

Interpace Biosciences (IDXG) Long-Term Deferred Tax (2025 - 2026) Analysis & Trends

At the end of FY2025, Interpace Biosciences reported Long-Term Deferred Tax of $21.25 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 102.25 Bn 101.69 Bn -
2 Natera 58.01 Bn 53.69 Bn 485.19 Mn
3 Labcorp Holdings 26.62 Bn 24.38 Bn 1.11 Bn
4 Quest Diagnostics 26.61 Bn 24.70 Bn 1.04 Bn
5 Guardant Health 22.59 Bn 18.65 Bn 219.03 Mn
6 Tenet Healthcare 21.62 Bn 12.76 Bn -
7 Fresenius Medical Care AG 12.67 Bn 5.74 Bn 1.52 Bn
8 Encompass Health 12.25 Bn 12.72 Bn -
9 BrightSpring Health Services 11.87 Bn 10.21 Bn 492.75 Mn
10 Interpace Biosciences 180.06 Mn 170.78 Mn 5.65 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 20.92 Mn
Mar 31, 2026 20.98 Mn
Dec 31, 2025 21.25 Mn
API Access

Interpace Biosciences Long-Term Deferred Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-deferred-tax&ticker=IDXG&period=max&api_key=YOUR_API_KEY